Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Rhabdomyosarcoma 3Hodgkin Disease 3Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Neoplasms 1Lung Neoplasms 1Lung Diseases, Interstitial 1HR+HER2- Breast Cancer 1Desmoplastic Small Round Cell Tumor 1Adenocarcinoma 1

Interventions

pembrolizumab 1Vinorelbine 1Surveys and Questionnaires 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Observation 1Nivolumab 1Hypnosis 1Health Records, Personal 1Gemcitabine 1Dexamethasone 1Carboplatin 1Bevacizumab 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases, Interstitial × Vinorelbine × 90 days × Clear all
NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
108 enrolled

Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡